In cancer cell studies, dihydroartemisinin inhibits proliferation and migration and triggers the ferroptosis of glioma cells by upregulating the ferroptosis-inducing HMOX1 gene and downregulating the ferroptosis-inhibiting GPX4 gene [69]. Here, GPX4 is linked to central nervous system cancer.